RecruitingNCT04336020
The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) Study
The DETECT (Digital Engagement & Tracking for Early Control, & Treatment) Study
Sponsor
Scripps Translational Science Institute
Enrollment
100,000 participants
Start Date
Mar 24, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Develop an app-based nationwide study of individuals who routinely use a smartwatch or other wearable activity tracker to determine if individualized tracking of changes in heart rate, activity and sleep can provide an early indication of influenza-like illnesses (ILI) and possibly other viral infections.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Living in the U.S.
- years or older
- Android or iPhone Smartphone user
- Any connected wearable (Apple Watch, Fitbit, Garmin watch connected to Apple Health or Google Fit, Amazfit)
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04336020
Related Trials
Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.
NCT076455341 location
Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies
NCT047721701 location
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
NCT07159763181 locations
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
NCT013864241 location
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
NCT039113883 locations